Transcript
Alfredo Butera
Azienda Sanitaria Provinciale di Agrigento
U.O.C. Oncologia
V European Conference on Survivors and Chronic Cancer Patients
Palazzo Vermexio - Siracusa Friday - June 6th 2014
Hepatocellular carcinoma
Gemcitabine-Oxaliplatin Combo Effective in Advanced Liver Cancer
Journal of Hepatology 2012 September 17.
204 patients with advanced HCC treated between 2001 and 2010.
disease control rate was 66% tumor downstaging 8,5 %
Median progression free survival was 4.5 months
Median overall survival was 11 months
Julien Taieb et al .;